The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,.
Panoramic Investment Advisors LLC acquired a new position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 6,500 shares of the biopharmaceutical company’s stock, valued at approximately $258,000. A number of other large investors […]
Panoramic Investment Advisors LLC bought a new stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 6,500 shares of the biopharmaceutical company’s stock, valued at approximately $258,000. A number of other institutional investors and hedge funds also […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Position Boosted by Polar Capital Holdings Plc theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Polar Capital Holdings Plc Purchases 10,000 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.